Bruno Michel

1.2k total citations
95 papers, 828 citations indexed

About

Bruno Michel is a scholar working on Geriatrics and Gerontology, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bruno Michel has authored 95 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Geriatrics and Gerontology, 16 papers in Psychiatry and Mental health and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bruno Michel's work include Pharmaceutical Practices and Patient Outcomes (24 papers), Renin-Angiotensin System Studies (9 papers) and Pharmacovigilance and Adverse Drug Reactions (9 papers). Bruno Michel is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (24 papers), Renin-Angiotensin System Studies (9 papers) and Pharmacovigilance and Adverse Drug Reactions (9 papers). Bruno Michel collaborates with scholars based in France, United States and Switzerland. Bruno Michel's co-authors include Randal A. Skidgel, Mariette Barthelmebs, M. Beck, Ervin G. Erdös, Julia Wang, B. Gourieux, Peter A. Deddish, Emmanuel Andrès, Christelle Sordet and Jean Sibilia and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Kidney International.

In The Last Decade

Bruno Michel

86 papers receiving 794 citations

Peers

Bruno Michel
M Lévy Israel
Paul Smits Netherlands
Philip E. Empey United States
C Aguirre Spain
Bruno Michel
Citations per year, relative to Bruno Michel Bruno Michel (= 1×) peers Fernando Martínez Martínez

Countries citing papers authored by Bruno Michel

Since Specialization
Citations

This map shows the geographic impact of Bruno Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Michel more than expected).

Fields of papers citing papers by Bruno Michel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Michel. The network helps show where Bruno Michel may publish in the future.

Co-authorship network of co-authors of Bruno Michel

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Michel. A scholar is included among the top collaborators of Bruno Michel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Michel. Bruno Michel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keller, Nicolas, et al.. (2024). Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease. RMD Open. 10(1). e003872–e003872. 3 indexed citations
2.
Potier, A., et al.. (2024). Clinical risk assessment of modelled situations in a pharmaceutical decision support system: a modified e-Delphi exploratory study. International Journal of Clinical Pharmacy. 46(3). 727–735. 1 indexed citations
3.
Javelot, Hervé, Gabriele Meyer, Giuliano Becker, et al.. (2021). Les échelles anticholinergiques : usage en psychiatrie et mise à jour de l’échelle d’imprégnation anticholinergique. L Encéphale. 48(3). 313–324. 4 indexed citations
4.
Meyer, Nicolás, et al.. (2019). Potential Statin Overuse in Older Patients: A Retrospective Cross-Sectional Study Using French Health Insurance Databases. Drugs & Aging. 36(10). 947–955. 3 indexed citations
5.
Javelot, Hervé & Bruno Michel. (2018). L’axe « microbiote-intestin-cerveau » : vers de nouvelles approches thérapeutiques en psychiatrie ?. 24(3). 176–182. 1 indexed citations
6.
Javelot, Hervé, et al.. (2018). High-dose quetiapine and therapeutic monitoring. European Journal of Hospital Pharmacy. 26(5). 285–287. 4 indexed citations
7.
Weill, François, et al.. (2017). Indication et prescription des antiagrégants plaquettaires : focus chez la personne âgée. 23(2). 80–89. 1 indexed citations
8.
Rousseau, Amélie, et al.. (2016). Prescriptions et administrations inappropriées de médicaments dans dix établissements alsaciens d’hébergement pour personnes âgées dépendantes – France. Revue d Épidémiologie et de Santé Publique. 64(2). 95–101. 10 indexed citations
9.
Michel, Bruno, et al.. (2016). Drug-dispensing problems community pharmacists face when patients are discharged from hospitals: a study about 537 prescriptions in Alsace. International Journal for Quality in Health Care. 28(6). 779–784. 10 indexed citations
10.
Beck, M., et al.. (2015). Cartographie des risques liés à la prise en charge médicamenteuse en EHPAD : état des lieux en région Alsace – France. Revue d Épidémiologie et de Santé Publique. 63(3). 163–172. 5 indexed citations
11.
Beretz, L., et al.. (2013). Potential clinical impact of medication discrepancies at hospital admission. European Journal of Internal Medicine. 24(6). 530–535. 92 indexed citations
12.
Michel, Bruno, et al.. (2012). Évaluation des pratiques de prescription relatives à 6 médicaments facturés en sus des GHS en Alsace. Therapies. 67(3). 205–211. 2 indexed citations
13.
Michel, Bruno, et al.. (2011). Lésions cutanées à type de leucémie congénitale « aleucémique » de rémission spontanée. Annales de Dermatologie et de Vénéréologie. 138(8-9). 586–590. 5 indexed citations
14.
Michel, Bruno, et al.. (2009). Le traitement médicamenteux personnel du patient lors des hospitalisations de chirurgie programmée : état des lieux, commentaires et propositions. Journal de Pharmacie Clinique. 28(1). 39–46. 6 indexed citations
15.
Dandurand, M., Bruno Michel, Claude Fabre, P Stoebner, & L. Meunier. (2009). Syndrome de Volkmann néonatal. Annales de Dermatologie et de Vénéréologie. 136(11). 785–789. 10 indexed citations
16.
Dandurand, M., et al.. (2006). Mycosis fongoïde tumoral et pilotrope sans mucine : évolution vers une érythrodermie pustuleuse. Annales de Dermatologie et de Vénéréologie. 133(2). 149–152. 4 indexed citations
17.
Michel, Bruno, et al.. (1997). Renal Tissue Angiotensins During Converting Enzyme Inhibition in the Spontaneously Hypertensive Rat. Clinical and Experimental Hypertension. 19(5-6). 671–685. 9 indexed citations
18.
Deddish, Peter A., Herbert L. Jackman, Bruno Michel, et al.. (1996). Single-domain angiotensin I converting enzyme (kininase II): characterization and properties.. Journal of Pharmacology and Experimental Therapeutics. 279(3). 1582–1589. 45 indexed citations
19.
Michel, Bruno, et al.. (1994). Effects of dietary protein and uninephrectomy on renal angiotensin converting enzyme activity in the rat. Kidney International. 45(6). 1587–1592. 11 indexed citations
20.
Michel, Bruno, et al.. (1978). The impact of cranial computerized tomography on electroencephalography.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 123–32. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026